Trends in Day 100 and 2-Year Survival After Auto-SCT for AL Amyloidosis: Outcomes Before and After 2006

Bone Marrow Transplantation- United Kingdom

doi 10.1038/bmt.2010.234

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

A Second Course of High-Dose Melphalan and Auto-SCT for the Treatment of Relapsed AL Amyloidosis

Bone Marrow Transplantation
TransplantationHematology
2010English

Correction: Before and After the "Appointed Day"

BMJ
1983English

Matched-Pair Analysis to Compare the Outcomes of a Second Salvage Auto-SCT to Systemic Chemotherapy Alone in Patients With Multiple Myeloma Who Relapsed After Front-Line Auto-SCT

Bone Marrow Transplantation
TransplantationHematology
2012English

Day 100 Risk Assessment Tool Predicts 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

The Cost of Dying: Charges Before Day 100 Predictive of Overall Survival

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Grading Cardiac Response in AL Amyloidosis: Implications for Relapse and Survival

British Journal of Haematology
Hematology
2018English

Four-Year Survival (And Counting) After Stereotactic Radiosurgery to Nearly 100 Brain Metastases: A Case Report

Cureus
2018English

Meta-Analysis Comparing Outcomes Before and After Resuscitation Guideline Updates After Cardiac Arrest

American Journal of Cardiology
Cardiovascular MedicineCardiology
2020English

Necrotizing Fasciitis and the Midterm Outcomes After Survival

SAGE Open Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy